#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	5842	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2369	487.2	0	.	n	.	0	C1450T	SNP	1450	1450	C	1884	1884	T	605	T	396	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	5842	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2369	487.2	1	SNP	n	C1184T	0	.	.	1184	1184	C	1618	1618	C	769	C,A	502,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	10732	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3774	551.2	0	.	n	.	0	T695C	SNP	695	695	T	1173	1173	C	776	C,G	485,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	10732	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3774	551.2	0	.	n	.	0	G1337A	SNP	1337	1337	G	1815	1815	A	615	A,G	399,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	10732	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3774	551.2	0	.	n	.	0	A1638G	SNP	1638	1638	A	2116	2116	G	544	G,T	373,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	10732	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3774	551.2	0	.	n	.	0	T1971C	SNP	1971	1971	T	2449	2449	C	585	C,G,T	378,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	10732	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3774	551.2	1	SNP	n	A2045G	0	.	.	2045	2045	A	2523	2523	A	572	A	364	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	10732	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3774	551.2	1	SNP	n	C2597T	0	.	.	2597	2597	C	3075	3075	C	684	C	453	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	10732	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3774	551.2	0	HET	.	.	.	C2525T	.	2525	2525	C	3003	3003	C	655	C,T	328,120	.	.
folP.WHO_O_01412c	folP.WHO_O_01412c	1	1	27	452	folP	855	855	100.0	folP.l15.c4.ctg.1	1597	55.3	1	SNP	p	R229S	1	.	.	685	687	AGC	1028	1030	AGC	76;75;75	A;G;C	50;49;49	folP.WHO_O_01412c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	1142	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3230	69.7	1	SNP	p	S91F	1	.	.	271	273	TTC	537	539	TTC	87;87;87	T;T;C	56;56;58	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	1142	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3230	69.7	1	SNP	p	D95G	1	.	.	283	285	GGC	549	551	GGC	90;90;90	G;G;C	60;60;58	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	1142	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3230	69.7	1	SNP	p	G95N	0	.	.	283	285	GGC	549	551	GGC	90;90;90	G;G;C	60;60;58	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	27	376	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1487	54.3	1	SNP	p	G45D	0	.	.	133	135	GGC	440	442	GGC	122;122;122	G;G;C	76;77;74	mtrR.WHO_O_01438:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	252	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	1030	48.7	0	.	n	.	0	A197.	DEL	197	197	A	641	641	A	110	A	75	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1022	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2794	71.3	1	SNP	p	D86N	0	.	.	256	258	GAC	463	465	GAC	97;97;98	G;A,T;C	63;60,1;66	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1022	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2794	71.3	1	SNP	p	S87R	1	.	.	259	261	CGT	466	468	CGT	97;97;97	C;G,T;T	70;66,1;68	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1022	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2794	71.3	1	SNP	p	R87I	0	.	.	259	261	CGT	466	468	CGT	97;97;97	C;G,T;T	70;66,1;68	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1022	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2794	71.3	1	SNP	p	R87W	0	.	.	259	261	CGT	466	468	CGT	97;97;97	C;G,T;T	70;66,1;68	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1022	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2794	71.3	1	SNP	p	S88P	0	.	.	262	264	TCC	469	471	TCC	97;96;96	T,C;C,T;C	68,1;67,1;70	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	806	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2676	59.8	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1529	1531	GGC	39;39;39	G;G;C	25;28;23	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.41.001	penA.41.001	1	1	27	1076	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2306	89.4	1	SNP	p	A311V	0	.	.	931	933	GCA	1284	1286	GCA	134;135;135	G;C;A	90;91;89	penA.41.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.41.001	penA.41.001	1	1	27	1076	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2306	89.4	1	SNP	p	I312M	0	.	.	934	936	ATC	1287	1289	ATC	142;142;141	A;T,A;C	94;96,1;97	penA.41.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.41.001	penA.41.001	1	1	27	1076	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2306	89.4	1	SNP	p	V316T	0	.	.	946	948	GTG	1299	1301	GTG	144;143;143	G;T,G,A;G	95;94,1,1;94	penA.41.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.41.001	penA.41.001	1	1	27	1076	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2306	89.4	1	SNP	p	V316P	0	.	.	946	948	GTG	1299	1301	GTG	144;143;143	G;T,G,A;G	95;94,1,1;94	penA.41.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.41.001	penA.41.001	1	1	27	1076	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2306	89.4	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1803	1805	ACC	89;89;86	A;C,T;C	60;61,1;62	penA.41.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.41.001	penA.41.001	1	1	27	1076	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2306	89.4	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1857	1859	GCG	66;63;63	G,C;C;G	45,1;40;39	penA.41.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.41.001	penA.41.001	1	1	27	1076	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2306	89.4	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1857	1859	GCG	66;63;63	G,C;C;G	45,1;40;39	penA.41.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.41.001	penA.41.001	1	1	27	1076	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2306	89.4	1	SNP	p	G543S	1	.	.	1627	1629	AGC	1980	1982	AGC	76;78;81	A,C;G,A;C	50,2;53,1;56	penA.41.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.41.001	penA.41.001	1	1	27	1076	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2306	89.4	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1989	1991	GGC	74;73;73	G;G;C	50;48;47	penA.41.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.41.001	penA.41.001	1	1	27	1076	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2306	89.4	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2007	2009	CCG	67;67;67	C,G;C,G;G	38,4;41,2;44	penA.41.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	1846	ponA	2397	2397	100.0	ponA.l15.c30.ctg.1	3133	112.3	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1490	1492	CCG	61;61;62	C;C;G	40;44;41	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	472	porA	1146	1146	99.91	porA.l6.c4.ctg.1	1917	48.3	0	.	p	.	0	M83fs	FSHIFT	247	247	A	548	548	C	31	C	20	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	70	porB1a	984	297	90.7	porB1a.l15.c4.ctg.1	721	6.5	0	.	p	.	0	H217N	NONSYN	649	651	CAT	447	449	AAT	11;11;11	A;A;T	8;8;8	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	70	porB1a	984	297	90.7	porB1a.l15.c4.ctg.1	721	6.5	0	.	p	.	0	D218N	NONSYN	652	654	GAT	450	452	AAT	10;10;10	A;A;T	7;7;7	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	70	porB1a	984	297	90.7	porB1a.l15.c4.ctg.1	721	6.5	0	.	p	.	0	V226A	NONSYN	676	678	GTA	474	476	GCA	8;8;8	G;C;A,C	5;4;4,1	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	70	porB1a	984	297	90.7	porB1a.l15.c4.ctg.1	721	6.5	0	.	p	.	0	.	MULTIPLE	700	702	ACT	497	499	GTA	8;8;8	G,T;T;A	4,1;5;5	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	70	porB1a	984	297	90.7	porB1a.l15.c4.ctg.1	721	6.5	0	.	p	.	0	S236N	NONSYN	706	708	AGC	503	505	AAC	8;8;8	A;A;C	5;5;5	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	70	porB1a	984	297	90.7	porB1a.l15.c4.ctg.1	721	6.5	0	.	p	.	0	.	MULTIPLE	709	711	AAC	507	512	TGGCAT	8;8;7;7;9;9	T;G;G;C;A;T	5;5;5;5;6;6	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	70	porB1a	984	297	90.7	porB1a.l15.c4.ctg.1	721	6.5	0	.	p	.	0	D238A	NONSYN	712	714	GAT	513	515	GCT	9;9;9	G;C;T	6;6;6	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	70	porB1a	984	297	90.7	porB1a.l15.c4.ctg.1	721	6.5	0	.	p	.	0	V258L	NONSYN	772	774	GTA	573	575	TTA	10;10;10	T;T;A	7;7;7	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	70	porB1a	984	297	90.7	porB1a.l15.c4.ctg.1	721	6.5	0	.	p	.	0	Y273H	NONSYN	817	819	TAT	618	620	CAT	11;7;7	C;A;T	7;5;5	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	70	porB1a	984	297	90.7	porB1a.l15.c4.ctg.1	721	6.5	0	.	p	.	0	D274G	NONSYN	820	822	GAT	621	623	GGT	7;7;7	G;G;T	5;5;5	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	70	porB1a	984	297	90.7	porB1a.l15.c4.ctg.1	721	6.5	0	.	p	.	0	N277Y	NONSYN	829	831	AAC	630	632	TAC	7;7;7	T;A;C	5;5;5	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	656	porB1b	1047	1047	98.95	porB1b.l15.c4.ctg.1	1713	77.0	0	.	p	.	0	N38E	NONSYN	112	114	AAT	527	529	GAA	119;118;119	G;A;A	83;82;83	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	656	porB1b	1047	1047	98.95	porB1b.l15.c4.ctg.1	1713	77.0	1	SNP	p	D121N	1	D121N	NONSYN	361	363	GAC	776	778	AAC	77;77;77	A;A;C	58;57;58	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	656	porB1b	1047	1047	98.95	porB1b.l15.c4.ctg.1	1713	77.0	0	.	p	.	0	N134D	NONSYN	400	402	AAT	815	817	GAT	74;77;77	G;A;T	54;55;54	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	656	porB1b	1047	1047	98.95	porB1b.l15.c4.ctg.1	1713	77.0	0	.	p	.	0	P175S	NONSYN	523	525	CCA	938	940	TCA	99;99;99	T;C;A	67;67;67	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	656	porB1b	1047	1047	98.95	porB1b.l15.c4.ctg.1	1713	77.0	0	.	p	.	0	A218I	NONSYN	652	654	GCC	1067	1069	ATC	111;115;114	A;TCCCC,TCCC;C	72;71,1;73	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	656	porB1b	1047	1047	98.95	porB1b.l15.c4.ctg.1	1713	77.0	0	.	p	.	0	R258H	NONSYN	772	774	CGT	1187	1189	CAT	115;114;114	C;A;T	73;72;72	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	656	porB1b	1047	1047	98.95	porB1b.l15.c4.ctg.1	1713	77.0	0	.	p	.	0	S295G	NONSYN	883	885	AGT	1298	1300	GGT	105;105;101	G;G;T,G	67;67;63,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	656	porB1b	1047	1047	98.95	porB1b.l15.c4.ctg.1	1713	77.0	0	.	p	.	0	E328A	NONSYN	982	984	GAA	1397	1399	GCA	95;95;89	G;C;A	61;61;57	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	656	porB1b	1047	1047	98.95	porB1b.l15.c4.ctg.1	1713	77.0	1	SNP	p	G120K	1	.	.	358	360	AAG	773	775	AAG	75;75;75	A;A;G,T	57;57;56,1	porB1b.WHO_V_02265c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	2946	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4740	122.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	288	rpsJ	312	312	100.0	rpsJ.l15.c30.ctg.1	1025	60.1	1	SNP	p	V57M	1	.	.	169	171	ATG	453	455	ATG	104;104;105	A;T;G	71;71;72	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
